Clinical Trial Update: Tivozanib As Maintenance Therapy In GYN [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tivozanib as maintenance therapy in gynecologic cancers was terminated, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Tivozanib (tivozanib)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Status: TERMINATED | Results posted: 2016-08-24